Test results
| Purity | 99.88% · HPLC · Spec ≥ 95.0% · Pass |
|---|---|
| Net peptide content | 21.46 mg · Report only |
| Identity | Confirmed · HPLC-RTM · TSM · Pass |
| Fentanyl screen | Not Detected · Immunoassay · 50 ng/mL cutoff · Pass |
| Product pH | 5.12 · Potentiometric pH (USP <791>) · Report only |
| Solubility | Soluble · Visual assessment · Nuclease-Free Water; 6.66 mg/mL; REPORT ONLY |
| Closure integrity | Pass · Vacuum Leak Test (USP <1207>) · No leakage observed; REPORT ONLY |
Batch details
| Product | Tesamorelin |
|---|---|
| Batch / lot | TSM201 |
| Certificate number | COA-2026-05SHSU |
| Laboratory | ILS Laboratories (ISO/IEC 17025 accredited) |
| Tested | Oct 16, 2026 |
| Labeled amount | 20mg |
| Method | Full QC Panel |
| Lab verdict | PASS |
Original certificate
Open the image for the full-size report. Match the lot number printed on your vial to TSM201. Every other batch of Tesamorelin is listed on its product page.
New to certificates of analysis? What is a COA? explains the tests on this page and how labs check identity and purity.
Other batches of Tesamorelin
- Batch TSM03, tested Sep 4, 2026
- Batch TSM501, tested Aug 24, 2026
- Batch TSM03, tested Jul 26, 2026
- Batch FX35, tested Apr 22, 2026
- Batch #32017, tested Feb 6, 2026
- Batch #29107, tested Nov 3, 2025